Richtlinien zur Einreichung von Proben
What Is AI-Assisted Microbiome Data Analysis
Microbiome data analysis characterizes the composition and function of a microbial community from sequencing data, whether targeted (16S/18S/ITS amplicon), whole-community DNA (shotgun metagenomics), or whole-community RNA (metatranscriptomics). AI-assisted classification and feature-selection methods help identify which taxa or functions differ between research groups and which combinations form a candidate research signature.
Why Microbiome Data Needs AI-Assisted Analysis
Microbiome data is compositional, sparse, and high-dimensional: most taxa are absent or near-zero in most samples, and the number of features routinely exceeds the number of samples.
- Sparsity and compositionality: Standard statistical tests can be misleading on compositional, zero-inflated data without appropriate transformation and testing methods.
- High dimensionality: With thousands of taxa or gene families and comparatively few samples, feature selection and rigorous cross-validation are needed to avoid overfit, non-reproducible signatures.
Note: We select the classification and validation approach based on cohort size and study design, rather than reporting a single model's output as a final research signature.
16S amplicon sequencing gives genus-level taxonomic profiling at lower cost; shotgun metagenomics adds species/strain resolution and functional gene content; metatranscriptomics adds a measure of active expression.
Supported Microbiome Data Types and Inputs
16S/18S/ITS Amplicon Sequencing:
- Accepted input: raw FASTQ from amplicon sequencing, or processed ASV/OTU tables
- Resolution: genus-level (species-level with full-length amplicon data); cost-effective community profiling
- Accepted input: raw FASTQ from whole-community DNA sequencing, or processed taxonomic/functional profiles
- Resolution: species/strain-level taxonomy plus functional gene and pathway content
Metatranscriptomics:
Raw FASTQ from whole-community RNA sequencing, or processed expression profiles, used to assess which microbial genes and pathways are actively expressed rather than only present.
Project Entry Options: Data-to-Insight and Sample-to-Insight
Two ways to start a microbiome data analysis project
Data-to-Insight
- You provide existing 16S, shotgun metagenomic, or metatranscriptomic sequencing data
- We handle QC, taxonomic/functional profiling, differential abundance, and ML biomarker analysis
- Best for labs with microbiome data already generated in-house or from a prior vendor
Sample-to-Insight
- You provide biological samples; qualified partner platforms generate the sequencing data
- Data then flows into the same AI-assisted microbiome analysis pipeline
- Best for teams that need one coordinated project spanning sample processing and analysis
AI-Assisted Microbiome Data Analysis Workflow
Our workflow connects sample or data intake, taxonomic and functional profiling, AI-assisted feature selection, and biomarker interpretation into one project plan, with QC checkpoints at every stage.
Step 1: Project Start
Project discussion to confirm the data type (16S, shotgun metagenomic, or metatranscriptomic), project entry option, and analysis plan.
Step 2: Sample / Data Reception & QC
Sample QC and processing coordination for Sample-to-Insight projects; read quality, adequate depth, and metadata review for submitted data.
Step 3: Taxonomic & Functional Profiling
Taxonomic classification and, for shotgun and metatranscriptomic data, functional gene and pathway annotation.
Step 4: AI-Assisted Feature Selection & Modeling
Compositionally aware differential abundance testing, feature selection, and classification modeling with nested cross-validation.
Step 5: Interpretation & Delivery
Biological interpretation of candidate taxa or pathways, delivery of the analysis report, and reproducible code.
Choosing the Right Microbiome Data Type
More sequencing depth or resolution is not always necessary. We help match the data type to the research question and budget.
| Data Type | Question It Answers | Resolution | Typical Use |
|---|---|---|---|
| 16S/18S/ITS Amplicon | Which taxa are present, and in what relative abundance? | Genus-level (species-level with full-length amplicon) | Cost-effective community screening, large cohort studies |
| Shotgun Metagenomics | Which taxa (to species/strain level) and which functional genes are present? | Species/strain-level taxonomy plus functional content | Mechanistic and functional studies, strain-level questions |
| Metatranscriptomics | Which microbial genes are actively expressed, not just present? | Species-level with expression-level functional resolution | Activity-focused studies where presence alone is not informative |
Validation and Quality Control
Microbiome findings are only as trustworthy as the validation behind them. Every project includes explicit checks for the failure modes most common in microbiome analysis.
- Compositionality and sparsity: Differential abundance testing uses methods appropriate for compositional, zero-inflated data rather than standard parametric tests
- Batch and cohort effects: Sequencing run, extraction batch, and cohort/site are evaluated as potential confounders before a taxon or pathway is reported as differential
- Overfitting in high-dimensional data: Nested cross-validation with feature selection confined to training folds; independent cohort or hold-out validation where sample size allows
Applications of Microbiome Data Analysis in Research
Microbiome data analysis supports a wide range of research questions across health, nutrition, and environmental research.
Gut, Oral, and Skin Microbiome Research
Compare community composition and function between research groups defined by health status, diet, or environmental exposure.
Candidate Microbial Biomarker Discovery
Identify taxa or functional features whose abundance pattern is associated with a research phenotype, for further study.
Nutrition and Diet Response Research
Characterize how community composition or function shifts in response to a dietary intervention or exposure.
Drug Response and Host-Microbiome Interaction Research
Study associations between microbiome composition and research measures of treatment response.
Multi-Omics Integration with Host Data
Correlate microbiome features with host transcriptomic, proteomic, or metabolomic data for a combined research view.
Deliverables
- Per-sample QC report
- Taxonomic and, where applicable, functional profile tables with diversity metrics
- Differential abundance results between research groups
- Candidate microbial biomarker panel with feature-selection and cross-validation results
- Reproducible analysis code and environment files
- Methods-ready write-up describing the analysis approach and validation strategy
Sample and Data Requirements
Minimum requirements vary by data type; the table below summarizes typical starting points.
| Data Type | Accepted Input | Typical Minimum | Recommended Metadata |
|---|---|---|---|
| 16S/18S/ITS Amplicon | Raw FASTQ, or processed ASV/OTU table | Read depth meeting platform QC thresholds per sample | Sample type, extraction kit, primer region, sequencing run/batch |
| Shotgun Metagenomics | Raw FASTQ, or processed taxonomic/functional profile | Sequencing depth adequate for the target resolution (discuss with project manager) | Sample type, extraction kit, host DNA depletion method, sequencing run/batch |
| Metatranscriptomics | Raw FASTQ, or processed expression profile | Sequencing depth adequate for target pathways (discuss with project manager) | Sample type, RNA extraction and preservation method, sequencing run/batch |
| For Sample-to-Insight projects, minimum sample mass and collection/storage requirements follow the standards of the selected wet-lab platform for each data type. | |||
Study Design Requirements
- Adequate sample size per group relative to the number of taxa or features under comparison
- Clearly defined groups, phenotypes, or exposure variables for differential abundance and classification analysis
- Documented extraction kit, sequencing run, and collection protocol for every sample, to support batch-effect evaluation
- Matched negative (extraction/reagent) controls where feasible, particularly for low-biomass samples
- An independent validation cohort or hold-out set, where available, strengthens any biomarker claim
Limitations
- Results are intended for research use only and are not validated for diagnostic, clinical, or treatment-decision use
- Small sample sizes and class imbalance limit the reliability of classification models even with cross-validation
- Low-biomass samples are especially sensitive to contamination and extraction batch effects
- Association between a microbial feature and a phenotype does not establish causality; findings support hypothesis generation and should be confirmed with orthogonal or experimental validation
Reference
- Pasolli, Edoardo, et al. "Machine Learning Meta-analysis of Large Metagenomic Datasets: Tools and Biological Insights." PLoS Computational Biology 12.7 (2016): e1004977. https://doi.org/10.1371/journal.pcbi.1004977
- Topçuoğlu, Begüm D., et al. "A Framework for Effective Application of Machine Learning to Microbiome-Based Classification Problems." mBio 11.3 (2020): e00434-20. https://doi.org/10.1128/mBio.00434-20
- Walsh, Ian, et al. "DOME: recommendations for supervised machine learning validation in biology." Nature Methods 18.10 (2021): 1122-1127. https://doi.org/10.1038/s41592-021-01205-4
- Yu, Ying, et al. "Assessing and mitigating batch effects in large-scale omics studies." Genome Biology 25 (2024): 254. https://doi.org/10.1186/s13059-024-03401-9
Demo Results
Classification Performance Across 16S and Shotgun Metagenomic Feature Types (Sun Y et al., Microbiome Res Rep, 2025)
Leave-One-Dataset-Out Validation Across International Cohorts (Sun Y et al., Microbiome Res Rep, 2025)
Feature-Level Comparison for Disease-Associated Taxonomic Signal (Sun Y et al., Microbiome Res Rep, 2025)
References
- Sun Y, Huang Y, Li R, et al. Benchmarking and optimizing microbiome-based bioinformatics workflow for non-invasive detection of intestinal tumors. Microbiome Res Rep. 2025;4(4):43. https://doi.org/10.20517/mrr.2025.75
AI-Assisted Microbiome Data Analysis FAQs
1. Should I choose 16S amplicon or shotgun metagenomic sequencing?
It depends on the resolution and functional information your question needs. 16S amplicon sequencing is cost-effective for genus-level community screening across large cohorts; shotgun metagenomics adds species/strain-level resolution and functional gene content, at higher cost and computational demand. We help match the data type to your research question and budget during project planning.
2. Can this service diagnose a disease or health condition?
No. This service is for research use only. Any classification model or candidate biomarker panel we deliver is a research tool for hypothesis generation, not a validated diagnostic or clinical test, and should not be used for diagnosis or treatment decisions.
3. How small a cohort can still support microbiome biomarker analysis?
There is no fixed minimum, but very small cohorts are generally better suited to exploratory, descriptive analysis (diversity comparisons, taxonomic profiling) rather than supervised classification, where overfitting risk rises sharply as feature count exceeds sample count.
4. Can you integrate microbiome data with host omics data?
Yes. Microbiome features can be correlated with host transcriptomic, proteomic, or metabolomic data as part of a broader multi-omics integration project.
5. How do you guard against false-positive taxa or biomarker findings?
We use differential abundance methods appropriate for compositional, sparse data, evaluate batch and cohort confounding before reporting a finding, and apply nested cross-validation with feature selection confined to training folds, plus independent cohort validation where feasible.
AI-Assisted Microbiome Data Analysis Case Study
Independent Research Example
This publication is not a CD Genomics customer project.
Benchmarking and optimizing microbiome-based bioinformatics workflow for non-invasive detection of intestinal tumors
Journal: Microbiome Research Reports
Published: 1 December 2025
Background
Machine learning applied to gut microbiome data has potential as a non-invasive research tool for studying disease-associated community shifts, but variation in feature types, preprocessing, and classification algorithms makes it difficult to know which pipeline choices actually matter. This study systematically benchmarked microbiome bioinformatics workflows for classifying colorectal cancer and adenoma status.
Materials & Methods
Cohort
- 4,217 fecal samples
- Diverse global regions and datasets
- Colorectal cancer, adenoma, and control status
Data Types
- Shotgun metagenomic (WGS) sequencing
- 16S rRNA gene sequencing
- Multiple feature levels (species, genus, ASV)
- 6,468 unique analytical pipelines benchmarked
- Six ML algorithms compared (RF, XGBoost, MLP, KNN, Lasso, SVM)
- Cross-validation plus leave-one-dataset-out validation
Results
- Shotgun Metagenomic Data Generally Outperformed 16S Data
- Across the benchmarked pipelines, shotgun metagenomic (WGS) features generally achieved stronger classification performance than 16S rRNA features.
- Feature Level Mattered More Than Algorithm Choice Alone
- Species-level genome bin, species, and genus-level features showed the greatest discriminatory power for shotgun data.
- For 16S data, Amplicon Sequence Variant-based features yielded the best classification performance.
- Feature Selection Strategy Affected Reproducibility
- Specific feature selection tools, including the Wilcoxon rank-sum test, improved model performance and stability across the benchmarked pipelines.
- The dual cross-validation and leave-one-dataset-out validation strategy distinguished pipelines that generalized across cohorts from those that did not.
Conclusion
Systematically benchmarking thousands of microbiome bioinformatics pipelines showed that data type and feature level, not just classification algorithm choice, substantially affect research classification performance and cross-cohort generalizability. The study illustrates the value of rigorous, multi-pipeline benchmarking before treating any single microbiome-based model as a reliable research signature; this and comparable models remain research tools and are not diagnostic tests.
Reference
- Sun, Yangyang, et al. "Benchmarking and optimizing microbiome-based bioinformatics workflow for non-invasive detection of intestinal tumors." Microbiome Research Reports 4.4 (2025): 43. https://doi.org/10.20517/mrr.2025.75
Related Publications
Here are some publications that have been successfully published using our services or other related services:
Egr2 Deletion in Autoimmune-Prone C57BL6/lpr Mice Suppresses the Expression of Methylation-Sensitive Dlk1-Dio3 Cluster MicroRNAs
Journal: ImmunoHorizons
Year: 2023
The HLA class I immunopeptidomes of AAV capsid proteins
Journal: Frontiers in Immunology
Year: 2023
High-Fat Diets Fed during Pregnancy Cause Changes to Pancreatic Tissue DNA Methylation and Protein Expression in the Offspring: A Multi-Omics Approach
Journal: International Journal of Molecular Sciences
Year: 2024
See more articles published by our clients.
